Publication

Neurobiological Pathways Linking Acute Mental Stress to Impairments in Executive Function in Individuals with Coronary Artery Disease

Downloadable Content

Persistent URL
Last modified
  • 05/20/2025
Type of Material
Authors
    Kasra Moazzami, Emory UniversityMatthew T Wittbrodt, Emory UniversityBruno B Lima, Emory UniversityJeong H Kim, Emory UniversityZakaria Almuwaqqat, Emory UniversityAmit Shah, Emory UniversityIhab Hajjar, Emory UniversityFelicia Goldstein, Emory UniversityAllan Levey, Emory UniversityJonathon Nye, Emory UniversityJames Bremner, Emory UniversityLaura Vaccarino, Emory UniversityArshed Quyyumi, Emory University
Language
  • English
Date
  • 2021-01-01
Publisher
  • IOS Press
Publication Version
Copyright Statement
  • © 2021 – The authors. Published by IOS Press
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 5
Issue
  • 1
Start Page
  • 99
End Page
  • 109
Grant/Funding Information
  • This work was supported by grants P01 HL101398, R01 HL109413, R01HL109413-02S1, R01HL125246, K24HL077506, K24 MH076955, UL1TR000454, KL2TR000455, K23HL127251, and T32HL130025 from the National Institutes of Health.
Supplemental Material (URL)
Abstract
  • Background: Individuals with coronary artery disease (CAD) have worse executive function compared to the general population but the mechanisms are unknown. Objective: To investigate the role of acute mental stress (MS) on the executive function of patients with CAD. Methods: Participants with stable CAD underwent acute MS testing with simultaneous peripheral vascular function measurements and brain imaging using high resolution-positron emission tomography. Digital pulse wave amplitude was continuously measured using peripheral artery tonometry (PAT, Itamar Inc). Stress/rest PAT ratio (sPAT) of pulse wave amplitude during MS/baseline was calculated as a measure of microvascular constriction during MS. Plasma levels of catecholamine and interleukin-6 were assessed at baseline and after MS. Executive function was assessed both at baseline and at 2 years follow-up using the Trail Making Test parts A and B. Results: We studied 389 individuals with brain data available for 148 participants. Of this population follow-up cognitive assessments were performed in 226 individuals (121 with brain imaging). After multivariable adjustment for baseline demographics, risk factors, and medication use, a lower sPAT, indicating greater vasoconstriction, a higher inferior frontal lobe activation with MS, and increases in norepinephrine and IL-6 levels with MS were all independently associated with greater time to complete Trail B test.-38.4pt Conclusion: In response to acute MS, greater peripheral vasoconstriction, higher inferior frontal lobe brain activation, and increases in the levels of norepinephrine and IL-6 are associated with worse executive function.
Author Notes
  • Arshed A. Quyyumi, MD, Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, 1462 Clifton Road N.E. Suite 507, Atlanta, GA 30322, USA. Tel.: +1 404 727 3655; Fax: +1 404 712 8785; E-mail: aquyyum@emory.edu
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery
  • Health Sciences, Epidemiology

Tools

Relations

In Collection:

Items